← SynDRA
ALAPROCLATE
SynDRA canonical compound SYN0001964 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | SLC6A4 |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Serotonin receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CBX1
- CYP3A4
- DRD1
- EHMT2
- GLP1R
- GMNN
- IDH1
- KCNH2
- LMNA
- NLRP3
- PMP22
- SLCO1B1
- SLCO1B3
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP1A2
- CP2C9
- CP2CJ
- CP2D6
- CP3A4
- CP3A7
- NTM1A
- NTMT1
Drug classes
- Antidepressive Agents
- Selective Serotonin Reuptake Inhibitors
ATC classes
Cross-references
Synonyms
- Alaproclato
- GEA-654
- NSC-758657
- Alaproclatum
- NSC 758657
- C4R42570ZO
- DL-Alanine, 2-(4-chlorophenyl)-1,1-dimethylethyl ester
- DTXCID3025122
- RefChem:553261
- A-23189
- N06AB07
- 1-(4-chlorophenyl)-2-methylpropan-2-yl 2-aminopropanoate
- [1-(4-chlorophenyl)-2-methylpropan-2-yl] 2-aminopropanoate
- NCGC00015012-02
- MLS002153522
- Alaproclate [USAN:INN]
- Alaproclatum [INN-Latin]
- Alaproclato [INN-Spanish]
- CAS-60719-82-6
- SMR001230852
- UNII-C4R42570ZO
- SR-01000075538
- DL-Alanin 4-chlor-alpha,alpha-dimethylphenethylester
- DL-Alanine p-chloro-alpha,alpha-dimethylphenethyl ester
- SirT1-enhancer-A03
- Spectrum_001468
- 4-Chlor-alpha,alpha-dimethylphenethyl (RS)-2-aminopropionat
- SpecPlus_000836
- Spectrum2_001653
- Spectrum3_001626
- Spectrum4_000594
- Spectrum5_001309
- ALAPROCLATE [INN]
- Alaproclate (USAN/INN)
- ALAPROCLATE [USAN]
- ALAPROCLATE [MART.]
- Lopac0_000127
- SCHEMBL34357
Look up ALAPROCLATE in the interactive SynDRA portal →